Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Eli Lilly -- Ignore unavailable to you. Want to Upgrade?

To: Anthony Wong who wrote (255)	6/16/1998 11:07:00 AM
From: Anthony Wong	Read Replies (1) \| Respond to of 642

Eli Lilly's Loses Chinese Court Appeal to Protect Prozac Bloomberg News June 16, 1998, 3:28 a.m. PT Beijing, June 16 (Bloomberg) -- Eli Lilly & Co. has had its appeal for protection in China for protection against copying of its Prozac-brand anti-depressant drug thrown out by a Beijing court, a company spokesman said. Lilly was trying to overturn a decision by China's State Pharmaceutical Administration not to grant protection for the drug. At least two Chinese companies now make generic copies of the drug, costing Lilly millions of dollars in lost sales. The company spokesman Lilly would now appeal to the Supreme Court to have its patent recognized. In May, Lilly company officials said the ruling would limit foreign investment in China's $6 billion-a-year pharmaceutical industry. President Bill Clinton is reported to have raised Lilly's case during talks last October with visiting Chinese President Jiang Zemin. Clinton will visit China next week. --Peter Hannam in the Beijing bureau (8610) 6532-4492 through the